July 14, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Adults with type 2 diabetes may be more likely to report smell and taste disturbances if they were prescribed a GLP-1 receptor agonist, according to data published in JAMA Otolaryngology – Head & Neck Surgery. In an analysis of data from the TriNetX electronic health records database, researchers compared smell and taste disturbances among adults with type 2 diabetes who were prescribed a
July 14, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Small increased risks emerge in review of EHR data

Adults with obesity who reported more intense tastes while receiving semaglutide or tirzepatide had a higher likelihood for…

GLP-1 receptor agonist therapy was associated with an increased risk for hair loss among adults with type 2 diabetes compared…

Data collected from a number of clinical trials found that despite recent “buzz,” there is no significant link between GLP-1…

GLP-1 receptor agonists were associated with a higher risk for eye complications vs. other diabetes medications, two studies…

Adults with type 2 diabetes have a similar likelihood for insulin discontinuation if they were using a concomitant GLP-1 receptor…